Jacobson Pharma Corporation Limited (HK:2633) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jacobson Pharma Corporation Limited reported a robust financial performance for the fiscal year ended March 31, 2024, with revenue and profit from continuing operations climbing by 15.8% and 17.2%, respectively. The company’s overall profit for the year also saw a healthy increase of 14.4% compared to the previous year. Highlighting their confidence, the Board recommends a higher final dividend, bringing the total dividend for the year to HK35.02 cents per share, a significant increase from the previous year’s HK5.18 cents per share.
For further insights into HK:2633 stock, check out TipRanks’ Stock Analysis page.